Final Trades: Sabra Health Care, Apollo GLobal, Spotify and the IWD

The Investment Committee give you their top stocks to watch for the second half.

CNBC Television • Dec 10, 2025

NAV Monitor: U.S. REITs Close November At Lower Median Discount To Net Asset Value

The price-to-net asset value valuations for publicly listed US equity real estate investment trusts rose in November, after two consecutive months of decline. US equity REITs closed November at a median 18.2% discount to their consensus NAV per share estimates, according to S&P Global Market Intelligence data. Healthcare REITs posted the highest median premium to NAV.

Seeking Alpha • Dec 5, 2025

The State Of REITs: November 2025 Edition

The REIT sector has seen back-to-back tough months as it saw a modest average negative total return in September (-0.73%) and fell deeper into the red in October (-4.03%). Small cap REITs (-5.05%) had the worst performance in October. Micro caps (-2.81%), mid caps (-3.11%) and large caps (-4.45%) were also in negative territory albeit to a smaller degree. Only 21.66% of REIT securities had a positive total return in October.

Seeking Alpha • Nov 18, 2025

Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript

Sabra Health Care REIT, Inc. ( SBRA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Darrin Smith - Executive Vice President of Investments Michael Costa - Executive VP, CFO & Secretary Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division William John Kilichowski - Wells Fargo Securities, LLC, Research Division Seth Bergey - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good day, everyone.

Seeking Alpha • Nov 6, 2025

Sabra Reports Third Quarter 2025 Results; Updates 2025 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #3Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavi.

Business Wire • Nov 5, 2025

Sabra (SBRA) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Nov 6, 2025

Sabra Healthcare (SBRA) Meets Q3 FFO Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.37 per share a year ago.

Zacks Investment Research • Nov 6, 2025

Sabra (SBRA) Upgraded to Buy: Here's Why

Sabra (SBRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Nov 4, 2025

Sabra Health Care REIT, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #3Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.

Business Wire • Oct 22, 2025

Sabra Health Care: SHOP Model As A Value Catalyst

Sabra Health Care REIT is rated a buy with a target price of $19.22, driven by FFO growth and SHOP portfolio expansion. SBRA's shift toward a larger Senior Housing Operating Portfolio aims to capture higher NOI growth, though it introduces more volatility than NNN leases. The REIT offers a 6.6% dividend yield, with improving payout ratios and strong dividend sustainability supported by projected FFO growth.

Seeking Alpha • Oct 11, 2025